Neuropace Inc NPCE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:41 PM EDT
8.97quote price arrow up+0.46 (+5.41%)
Volume
94,431
52 week range
3.80 - 18.15
Loading...
  • Open8.73
  • Day High9.13
  • Day Low8.60
  • Prev Close8.51
  • 52 Week High18.15
  • 52 Week High Date02/20/24
  • 52 Week Low3.80
  • 52 Week Low Date06/07/23

Key Stats

  • Market Cap258.05M
  • Shares Out28.77M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change-12.71

KEY STATS

  • Open8.73
  • Day High9.13
  • Day Low8.60
  • Prev Close8.51
  • 52 Week High18.15
  • 52 Week High Date02/20/24
  • 52 Week Low3.80
  • 52 Week Low Date06/07/23
  • Market Cap258.05M
  • Shares Out28.77M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change-12.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.18
  • P/E (TTM)-7.58
  • Fwd P/E (NTM)-7.74
  • EBITDA (TTM)-26.231M
  • ROE (TTM)-150.63%
  • Revenue (TTM)69.073M
  • Gross Margin (TTM)73.97%
  • Net Margin (TTM)-45.61%
  • Debt To Equity (MRQ)404.71%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Neuropace Inc

 

Profile

MORE
NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal...
Frank Fischer
Chairman of the Board
Joel Becker
President, Chief Executive Officer, Director
Rebecca Kuhn
Chief Financial Officer and Vice President, Finance and Administration
Address
455 N. Bernardo Avenue
Mountain View, CA
94043
United States

Top Peers

SYMBOLLASTCHG%CHG
BFLY
Butterfly Network Inc
1.04+0.06+6.32%
SGHT
Sight Sciences Inc
5.54+0.09+1.74%
SMLR
Semler Scientific Inc
23.20-0.30-1.26%
LUNG
Pulmonx Corp
9.30+0.39+4.38%
MASS
908 Devices Inc.
7.11-0.04-0.56%